You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

02 June 2017

People living with HIV have increased risk of neurocognitive impairment when they grow older

In the era of highly active antiretroviral treatment, HIV-associated neurocognitive disorders (HAND) still affect people living with HIV as they get older

13 April 2017

Male involvement crucial for keeping women on Option B+ in Malawi

A lack of male involvement in their partner’s HIV treatment programme before and after pregnancy has been found to be one of the biggest challenges to retaining women in HIV care in Malawi.

14 March 2017

Kenyan experience highlights potential of Situation Room HIV mobile app

Just over a year since launch, a new mobile app is helping Kenya track progress, plan and allocate resources for the HIV response, providing useful learning for other countries.

21 February 2017

Pre-treatment drug resistance as high as 17% with no impact on viral load suppression

‘Surprising’ research from Conference on Retroviruses and Opportunistic Infections (CROI) shows drug resistance does not impact test-and-treat roll-out in South Africa – at least in the short term.

19 January 2017

Rural and urban patterns of HIV drug resistance in South Africa

HIV is more proactively monitored among urban HIV patients than rural patients, and drug resistance and treatment failure is less prevalent. However outcomes for second line treatment remain similar.

13 January 2017

Vaginal bacteria could play a key role in regulating HIV risk among women

Understanding the vaginal microbiome and how it impacts HIV risk could help develop more effective treatment and prevention strategies for young women in sub-Saharan Africa.

11 January 2017

Interventions to keep people in HIV care more cost-effective than a ‘treat all’ approach

Treatment scale-up has had major public health benefits. But where resources are scarce, interventions to keep people in care could be more cost-effective than moving to treat everybody living with HIV after diagnosis.